Assignee
ANEBULO PHARMACEUTICALS INC
US·3 granted patents·5 pending applications·6 citations·filing 2020–2024
Top patents by PatentIndex Score
8 records- 0188US11141404B1Formulations and methods for treating acute cannabinoid overdoseANEBULO PHARMACEUTICALS INC·Filed 2020·Granted Oct 12, 2021·4 cites·16 claims
- 0286US11795146B2Crystalline forms of a cannabinoid receptor type 1 (CB1) modulator and methods of use and preparation thereofANEBULO PHARMACEUTICALS INC·Filed 2022·Granted Oct 24, 2023·2 cites·17 claims
- 0372US12180155B2Crystalline forms of a cannabinoid receptor type 1 (CB1) modulator and methods of use and preparation thereofANEBULO PHARMACEUTICALS INC·Filed 2023·Granted Dec 31, 2024·0 cites·18 claims
- 0470US2025066295A1Crystalline forms of a cannabinoid receptor type 1 (cb1) modulator and methods of use and preparation thereofANEBULO PHARMACEUTICALS INC·Filed 2024·Application pending·0 cites
- 0562US2022151990A1Formulations and methods for treating acute cannabinoid overdoseANEBULO PHARMACEUTICALS INC·Filed 2021·Application pending·0 cites
- 0662US2024000748A1Formulations and methods for treating acute cannabinoid overdoseANEBULO PHARMACEUTICALS INC·Filed 2021·Application pending·0 cites
- 0761US2026091020A1Treatment of acute cannabinoid overdoseANEBULO PHARMACEUTICALS INC·Filed 2023·Application pending·0 cites
- 0855US2024408059A1Method of treating addictionANEBULO PHARMACEUTICALS INC·Filed 2022·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when ANEBULO PHARMACEUTICALS INC files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →